天康生物股份有限公司 2025 年半年度财务报告 天康生物股份有限公司 2025 年半年度财务报告 2025 年 8 月 1 天康生物股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 | 流动资产合计 | 8,776,473,163.57 | 9,847,752,197.03 | | --- | --- | --- | | 非流动资产： | | | | 发放贷款和垫款 | | | | 债权投资 | | | | 其他债权投资 | | | | 长期应收款 | | | | 长期股权投资 | 27,306,419.25 | 33,289,026.29 | | 其他权益工具投资 | | | | 其他非流动金融资产 | | | | 投资性房地产 | | | | 固定资产 | 5,663,754,827.16 | 5,889,854,376.07 | | 在建工程 | 287,882,470.85 | 233,094,837.82 | | 生产性生物资产 | 279,414,186.06 | 272,429,943.75 | | 油气资产 | | | | ...

天康生物股份有限公司 2025 年半年度募集资金存放与使用情况专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误 导性陈述或者重大遗漏。 根据中国证券监督管理委员会（以下简称"中国证监会"）《上市公司募集资金 监管规则》和深圳证券交易所《深圳证券交易所上市公司自律监管指引第1号——主 板上市公司规范运作》等的相关规定，天康生物股份有限公司（以下简称"公司"） 董事会编制了《2025年半年度募集资金存放与使用情况专项报告》。 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 经中国证券监督管理委员会《关于核准天康生物股份有限公司非公开发行股票的 批复》(证监许可[2021]1771号)核准，天康生物股份有限公司非公开发行不超过 322,540,482股新股。本次非公开发行实际发行数量277,449,664股，发行价格为人民 币7.45元/股，募集资金总额为人民币206,700.00万元，扣除承销保荐费共计2,191.02 万元后，实际募集资金净额为人民币204,508.98万元。上述募集资金到位情况已经希 格玛会计师事务所(特殊普通合伙)验审，并出具了希会验字(2021) ...

（一）审议并通过公司《2025 年半年度报告全文及摘要》的议案；（议案 内容详见刊登于 2025 年 8 月 30 日本公司指定信息披露报纸《证券时报》上的《天 康生物股份有限公司 2025 年半年度报告摘要》<公告编号：2025-050>和巨潮资 讯网 www.cninfo.com.cn 上披露的《天康生物股份有限公司 2025 年半年度报告 全文》） 本议案已经公司董事会审计委员会及独立董事专门会议审议通过。 天康生物 证券代码：002100 证券简称：天康生物 公告编号：2025-049 天康生物股份有限公司 第八届董事会第二十七次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 天康生物股份有限公司（以下简称"公司"）第八届董事会第二十七次会议 通知于 2025 年 8 月 18 日以书面专人送达和电子邮件等方式发出，并于 2025 年 8 月 28 日（星期四）上午 11：00 分以通讯表决方式召开，应到会董事 7 人，实 到会董事 7 人。公司高级管理人员列席了会议。会议符合《公司法》、《公司章 程》的规定，会议合法有效。本次会议由董 ...

天康生物8月29日披露半年报，公司上半年实现营业收入88.47亿元，同比增长10.68%；归属于上市公司 股东的净利润3.38亿元，同比增长22.27%；基本每股收益0.25元。 ...

天康生物股份有限公司 2025 年半年度报告全文 天康生物股份有限公司 2025 年半年度报告 2025 年 8 月 1 天康生物股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人张杰、主管会计工作负责人耿立新及会计机构负责人(会计主 管人员)段效岩声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 公司需遵守《深圳证券交易所上市公司自律监管指引第 3 号——行业信 息披露》中的"畜禽、水产养殖相关业务"的披露要求 | | | 天康生物股份有限公司 2025 年半年度报告全文 备查文件目录 一、载有法定代表人、主管会计工作负责人、会计机构负责人(会计主管人员）签名并盖章的财务报表； 公司在本报告第三节"管理层讨论与分析"之"十、公司面临的风险和应 对措施"部分,对风险及应对措施进行了详细描述。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 二、报告期内在中国证监 ...

Market Overview - The Asia-Pacific stock markets showed mixed results, with the Philippines index rising by 2.1% to 6,273 points, while the A-share and Hong Kong markets experienced declines of over 1%[3][21]. - U.S. stock indices reached new highs, with the Dow Jones up 0.3% to 45,565.2 points and the S&P 500 rising 0.2% to 6,481.4 points[8][9]. Economic Indicators - From January to July, China's industrial enterprises reported total profits of CNY 40,203.5 billion, a year-on-year decrease of 1.7%, while total revenue increased by 2.3% to CNY 78.07 trillion[6]. - In July, industrial profits fell by 1.5% year-on-year, indicating that the effects of anti-involution policies on corporate profitability may take time to materialize[17]. Commodity and Currency Markets - International oil prices rose over 1% due to a decline in U.S. crude and fuel inventories, with NYMEX crude oil increasing by 1.42% to $64.15 per barrel[4][27]. - Gold prices also saw a slight increase of 0.5%, closing at $3,404.6 per ounce, amid expectations of two rate cuts by the Federal Reserve by year-end[4][27]. Corporate Performance - Nvidia's Q2 earnings exceeded expectations by 7%, with a revenue growth of 56% year-on-year, although guidance for the next quarter was slightly below market expectations[9]. - Meituan reported disappointing Q2 results, with total revenue of CNY 918 billion, a year-on-year increase of only 11.7%, and an adjusted EBITDA down 86.8% to CNY 18 billion[15]. Sector Performance - In the U.S., the energy sector led gains with a rise of 1.15%, driven by a larger-than-expected reduction in oil inventories[9]. - In Hong Kong, the Hang Seng Index fell by 1.27% to 25,201 points, with significant pressure on technology and property stocks[11].

Group 1 - The poultry concept sector rose by 2.87%, ranking second in terms of increase among concept sectors, with 20 stocks rising, including Xiaoming Co., Tianma Technology, and Jingji Zhino, which increased by 10.34%, 8.15%, and 6.16% respectively [1][2] - The leading stocks in terms of net inflow of main funds include Xiaoming Co. with a net inflow of 71.28 million yuan, followed by Huadong Co., Tianma Technology, and Tiankang Biological with net inflows of 49.64 million yuan, 47.57 million yuan, and 35.89 million yuan respectively [1][2] - The main fund inflow rates for leading stocks are Huadong Co. at 12.51%, Guanghong Holdings at 11.56%, and Xiaoming Co. at 9.64% [2][3] Group 2 - The overall market performance shows that the poultry sector is gaining traction, with significant interest from main funds, indicating a positive sentiment towards the industry [1][2] - Stocks such as Jinlongyu, Yike Foods, and Shuanghui Development experienced declines of 0.84%, 0.25%, and 0.24% respectively, highlighting some volatility within the sector [1][3] - The trading volume and turnover rates for leading stocks in the poultry sector suggest active trading, with Xiaoming Co. having a turnover rate of 24.77% [2][3]

Market Overview - The feed sector increased by 1.07% on August 26, with Aonong Biological leading the gains [1] - The Shanghai Composite Index closed at 3868.38, down 0.39%, while the Shenzhen Component Index closed at 12473.17, up 0.26% [1] Individual Stock Performance - Aonong Biological (603363) closed at 4.15, up 10.08%, with a trading volume of 785,000 shares and a turnover of 318 million yuan [1] - Tianma Technology (603668) closed at 14.86, up 8.15%, with a trading volume of 411,700 shares and a turnover of 607 million yuan [1] - Bangji Technology (603151) closed at 27.04, up 5.42%, with a trading volume of 72,200 shares and a turnover of 26.8 million yuan [1] - Tiankang Biological (002100) closed at 6.97, up 5.29%, with a trading volume of 1,027,400 shares and a turnover of 706 million yuan [1] - Petty Holdings (300673) closed at 17.80, up 2.06%, with a trading volume of 140,200 shares and a turnover of 249 million yuan [1] Capital Flow Analysis - The feed sector saw a net inflow of 102 million yuan from main funds, while retail investors experienced a net outflow of approximately 95.23 million yuan [2] - Aonong Biological had a main fund net outflow of 94.44 million yuan, with retail investors also showing a net outflow of 45.43 million yuan [3] - Tianma Technology experienced a main fund net inflow of 61.12 million yuan, while retail investors had a net outflow of 28.96 million yuan [3]

截至2025年8月26日 14:41，中证农牧主题指数(931778)上涨2.41%，样本股牧原股份(002714)上涨 7.51%，天康生物(002100)上涨6.04%，江山股份(600389)上涨5.74%，东方铁塔(002545)，广信股份 (603599)等个股均上涨。 太平洋证券指出，生猪养殖行业反内卷调控政策近期密集发布，继发改委6月初提出了不增产能和降重 稳价倡议，以及农业部7月下旬召集养殖屠宰核心企业会议提出了严格落实产能调控举措之后，行业协 会8月13日召开会议倡议行业削减产能至3950万头，多家头部企业参会。会后业内龙头企业积极响应产 能调控政策，表态将削减能繁母猪存栏量。尽管育肥和扩繁环节持续盈利，但预计随着反内卷政策的继 续实施和规避疫情风险的影响，行业产能有望去化。 建信中证农牧主题ETF(159616)紧密跟踪中证农牧主题指数，中证农牧主题指数选取50只业务涉及粮食 种植、种子生产、农药化肥、农用机械、畜牧养殖、饲料生产以及动物保健等相关领域的上市公司证券 作为样本，以反映农牧主题上市公司证券的整体表现。 以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 近 ...

Group 1 - The poultry and pork sectors are experiencing significant activity, with notable stock price increases [1] - Aonong Bio and other companies such as Muyuan Foods, Lihua Stock, Tiankang Bio, and Xiaoming Stock have seen their stock prices rise [1]